| For: | Wang CD, Zhang BX, Song J. Lipid metabolic reprogramming in colorectal cancer: Insights to mechanisms and therapeutics. World J Gastrointest Oncol 2025; 17(10): 109398 [PMID: 41114120 DOI: 10.4251/wjgo.v17.i10.109398] |
|---|---|
| URL: | https://www.wjgnet.com/1009-3079/full/v17/i10/109398.htm |
| 编号 | Citing Articles |
| 1 |
Hanrui Liu, Tao Zhou, Laiyuan Wang, Fangchao Liu, Dongfeng Gu. The role of PCSK9 in cancer risk: Population-level evidence and mechanistic insights. Oncology and Translational Medicine 2026; doi: 10.1097/ot9.0000000000000141
|
| 2 |
ShuangShuang Zhang, Kunshan Li, Dong-Dong Yu, Ya-Ying Lin, Lu Zhu, Pei-Han Wang, Guo-Na Li, Yan Huang, Hong-Xiao Xu, Ming Zhang. Exploring the Relationship Between Colitis-Associated Cancer and Lipid Metabolism Reprogramming from the Perspective of Inflammation-Cancer Transformation. Journal of Inflammation Research 2026; doi: 10.2147/JIR.S583726
|
| 3 |
Gaurav Dutta, Priyanka Mishra, Sidharth P. Mishra, Jhasketan Badhai. Obesity as a Whole-Body Regulatory Disorder: A Systems Biology Framework for Metaflammation, Accelerated Aging, and Colorectal Cancer Risk. Onco 2026; 6(3) doi: 10.3390/onco6030031
|
| 4 |
Liang Zhang, Mengxin He, Yao Lu, Shuai Lu, Jianmin Ding, Hong Ji, Jun Kang, CongHui Han, Jun Yan. CD36‐Pocket Targeting Induces Metabolic Collapse and Disulfidoptosis for Sonodynamic Immunometabolic Therapy of Liver Cancer. Small 2026; doi: 10.1002/smll.75339
|